Navigation Links
Luminex Corporation Reports Third Quarter 2013 Results
Date:11/4/2013

diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets.  The Company's xMAP technology is sold worldwide and is in use in leading research laboratories as well as major pharmaceutical, diagnostic and biotechnology companies.  Further information on Luminex or xMAP can be obtained on the Internet at http://www.luminexcorp.com.

Statements made in this release that express Luminex's or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements. Forward-looking statements in this release include statements regarding: the expansion of our installed base of multiplexing systems; our efforts to sell our molecular diagnostic products directly to end users; the development progress of our pipeline products, market acceptance of our genetic and infectious disease products, regulatory clearance of our products; the ability of our investment in current initiatives and new products to deliver high performance solutions, and drive long-term value for our shareholders, the financial impact of recent corporate restructuring, status of molecular codes, the impact of delays of Medicare reimbursement on our customers and current and future impact on our business; and, projected 2013 revenue. The words "believe," "expect," "intend," "estimate," "anticipate," "will," "could," "should" and similar expressions are intended to further identify such forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.  It is important to note that the Company's actual results or performance could differ materially from those anticipated or projected in such forward-looking statements.  Factors that could cause Luminex's actual results or performance to differ materially include risks and uncertainties relating to, among others, market demand and acc
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. LUMINEX CORPORATION TO HOST INVESTOR EVENT AT ASSOCIATION FOR MOLECULAR PATHOLOGY ANNUAL MEETING
2. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
3. Luminex Corporation Reports Second Quarter 2013 Results
4. Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
5. Luminex Corporation Second Quarter Earnings Release Scheduled for July 29, 2013
6. Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporations xMAP Technology
7. Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
8. Luminex Corporation To Present At Upcoming Investment Conferences
9. Luminex Corporation Reports First Quarter 2013 Results
10. Luminex Corporation First Quarter Earnings Release Scheduled for April 29, 2013
11. Luminex Corporation Reports Fourth Quarter And Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 RoundTable Healthcare Partners ("RoundTable"), an ... healthcare industry, announced today the sale of Vesta ... Lubrizol, a Berkshire Hathaway company, is a specialty ... customers in the global transportation, industrial and consumer ... Vesta is an ISO-13485 certified medical ...
(Date:8/1/2014)... NORTH CHICAGO , Ill. and PALO ... (NYSE: ABBV) and Cystic Fibrosis Research, Inc. (CFRI) today announced ... in the cystic fibrosis (CF) community through the CFChef ... to September 15, 2014, as part of AbbVie,s CFChef ... caregivers – to encourage patients to maintain a healthy ...
(Date:8/1/2014)... Mass. , Aug. 1, 2014  NxStage Medical, Inc. ... dialysis products, today announced that Jeffrey H. Burbank , ... Officer, will present at the 34 th Annual Canaccord ... Boston, MA , on Wednesday, August 13 th ... will be made available at http://ir.nxstage.com/ .  ...
Breaking Medicine Technology:RoundTable Healthcare Partners Announces Sale of Vesta Funding, Inc. to The Lubrizol Corporation 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2
... 6, 2012  PAREXEL International Corporation (NASDAQ: PRXL ... that Ramita Tandon, Global Head, Late Phase Clinical Trials ... Operations at PAREXEL will address innovative approaches to late ... ( SCOPE ), to be held February 7-9, 2012 ...
... New York, February 6, 2012 In the news ... of USD 6.8 billion in 2015, China Osteoporosis Market Will be ... 11:30 GMT, by Transparency Market Research over PR Newswire, we are ... "Market Size of USD 6.8 billion" has been changed to "Market ...
Cached Medicine Technology:PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives 2PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives 3PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives 4CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015 2CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015 3CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015 4
(Date:8/1/2014)... New York (PRWEB) August 01, 2014 ... in the wake of the 2012 Rejuvenate and ... move forward in New Jersey’s Bergen County Superior ... filed in the proceeding, the Court has ... Confidentiality governing any and all hard copy and ...
(Date:8/1/2014)... Almost 140 people die every year in accidents ... But there are several simple ways to ... coordinator at Cincinnati Children,s Hospital Medical Center,s Comprehensive ... news release. "As families begin to prepare ... parents and children to go over school bus ...
(Date:8/1/2014)... 01, 2014 As it continues to ... women who allegedly experienced the spread of uterine cancers ... surgeries, Bernstein Liebhard LLP notes the growing reaction to ... power morcellators marketed by its Ethicon, Inc. unit from ... York Times, some critics of the company said they ...
(Date:8/1/2014)... 01, 2014 The evolving healthcare ... community pharmacies. At ThoughtSpot 2014, AmerisourceBergen and Good ... practices and resources to enhance patient care and ... on critical issues to give independent pharmacists the ... , ThoughtSpot show attendance experienced a nearly ...
(Date:8/1/2014)... gay, bisexual, and transgender individuals who want to conceive ... of their heterosexual and cisgendered peers, such as reduced ... physiological and legal challenges to become parents. A comprehensive ... options is presented in the article " LGBT Assisted ... LGBT Health , a peer-reviewed journal ...
Breaking Medicine News(10 mins):Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 3Health News:Expert Offers School Bus Safety Tips 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5Health News:Advances in assisted reproduction create more options and new legal issues for LGBT couples 2
... 16 Quantros, Inc., a leading provider of safety ... healthcare industry, announces the creation of a new healthcare ... Michael Tulloch, MBA, as Director of IT Consulting Services. ... office. , "The expansion into IT services is a ...
... procedures in cardiology. The idea of publishing an ESC ... European cardiovascular imagers, is therefore long awaited. The textbook ... a patient rather than technology-based approach, helping clinicians to ... of imaging. The book is divided into ...
... acid typically found in red meats, fish, beans, eggs, ... the risk of developing Alzheimer,s disease, according to a ... findings, titled "Diet-induced hyperhomocysteinemia increases Amyloid-β formation and deposition ... journal Current Alzheimer Research . "When methionine ...
... ... wellness programs have a positive impact on employee presenteeism and bottom line benefits. ... Minneapolis, MN (PRWEB) ... percent of employers have improved employee participation in health and wellness programs by implementing ...
... ... announce that Chris Wepfer and Jackie Kirby have been chosen as the company’s Recruiters ... is the second consecutive year that Chris has received such honors and the first ... ...
... , SCHAFFHAUSEN, Switzerland, Dec. 16 Tyco ... nomination of Michael E. Daniels for election to the Tyco ... March 10, 2010. , Daniels, 55, is Senior Vice ... Machines Corporation. In this role, he has worldwide responsibility for ...
Cached Medicine News:Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 2Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 3Health News:Diet high in methionine could increase risk of Alzheimer's 2Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: